Zobrazeno 1 - 10
of 39
pro vyhledávání: '"James H, Revkin"'
Autor:
Richard F. Dunne, Jeffrey Crawford, Karen E. Smoyer, Thomas D. McRae, Michelle I. Rossulek, James H. Revkin, Lisa C. Tarasenko, Philip D. Bonomi
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 15, Iss 5, Pp 1628-1640 (2024)
Abstract Cancer‐associated cachexia is a multifactorial wasting disorder characterized by anorexia, unintentional weight loss (skeletal muscle mass with or without loss of fat mass), progressive functional impairment, and poor prognosis. This syste
Externí odkaz:
https://doaj.org/article/19dd9656f57344eda2a3fd9a01e0f9ce
Autor:
Philip D. Bonomi, Jeffrey Crawford, Richard F. Dunne, Eric J. Roeland, Karen E. Smoyer, Mohd Kashif Siddiqui, Thomas D. McRae, Michelle I. Rossulek, James H. Revkin, Lisa C. Tarasenko
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 15, Iss 4, Pp 1226-1239 (2024)
Abstract Cachexia, with weight loss (WL) as a major component, is highly prevalent in patients with cancer and indicates a poor prognosis. The primary objective of this study was to conduct a meta‐analysis to estimate the risk of mortality associat
Externí odkaz:
https://doaj.org/article/016c983e09d6466f9c507694533f7f8a
Autor:
Ali Javaheri, Mualla Ozcan, Lauren Moubarak, Karen E. Smoyer, Michelle I. Rossulek, James H. Revkin, John D. Groarke, Lisa C. Tarasenko, Mikhail N. Kosiborod
Publikováno v:
Heliyon, Vol 10, Iss 16, Pp e35916- (2024)
Growth differentiation factor-15 (GDF-15) is an emerging biomarker in several conditions. This SLR, conducted following PRISMA guidelines, examined the association between GDF-15 concentration and range of adverse outcomes in patients with heart fail
Externí odkaz:
https://doaj.org/article/a13cd2767fc04939926e228b16fc96b5
Autor:
Gail D. Pearson, Faiez Zannad, Cindy L. Grines, Anuradha Lala, Monica R. Shah, Carolyn S.P. Lam, Roxana Mehran, Padma Kaul, Harriette G.C. Van Spall, James H. Revkin, Tabassome Simon, Mary Norine Walsh, Ileana L. Piña, Barbara Casadei, Annabelle Santos Volgman, Thomas F. Deering, Martha Gulati, Biykem Bozkurt, Judith S. Hochman, Women As One Scientific Expert Panel
Publikováno v:
Journal of the American College of Cardiology. 77:2960-2972
Women are under-represented as leaders of cardiovascular randomized controlled trials, representing 1 in 10 lead authors of cardiovascular trials published in high-impact journals. Although the proportion of cardiovascular specialists who are women h
Autor:
Jeffrey Crawford, Shannon Lubaczewski, Anil Tarachandani, Magdalena A. Harrington, Yan Weng, Ruolun Qiu, Susie M. Collins, Michelle I. Rossulek, James H. Revkin
Publikováno v:
Cancer Research. 83:CT054-CT054
Background: Cancer cachexia is a multifactorial metabolic syndrome of wasting characterized by anorexia, unintended weight loss, and decreased skeletal muscle mass, leading to progressive functional impairment, fatigue, diminished quality of life, po
Autor:
Jeffrey Crawford, Roberto A. Calle, Susie M. Collins, Yan Weng, Shannon L. Lubaczewski, Clare Buckeridge, Ellen Q. Wang, Magdalena A. Harrington, Anil Tarachandani, Michelle I. Rossulek, James H. Revkin
Publikováno v:
Cancer Research. 83:CT108-CT108
Background: Cachexia is common in patients with advanced cancer and has been associated with elevated serum growth/differentiation factor 15 (GDF-15) concentrations. This first-in-patient, phase 1b, study assessed the use of ponsegromab, a monoclonal
Autor:
Christoph P. Hornik, Daniel Keene, Jonathan H. Seltzer, Patricia Massicotte, Neil A. Goldenberg, Shetarra Walker, Mitchell W. Krucoff, Concetta Lipardi, Ann T. Farrell, Diptee A. Gajjar, Dirk Mentzer, Courtney D. Thornburg, Paul Monagle, James H. Revkin
Publikováno v:
American Heart Journal. 224:138-147
Autor:
Richard Francis Dunne, Philip D. Bonomi, Jeffrey Crawford, Karen E Smoyer, Thomas D McRae, Michelle I Rossulek, James H Revkin, Lisa C Tarasenko
Publikováno v:
Journal of Clinical Oncology. 41:87-87
87 Background: Cancer-associated cachexia is a multifactorial wasting disorder characterized by anorexia, unintentional weight loss (WL, skeletal muscle mass with or without loss of fat mass), progressive functional impairment, and poor prognosis. Th
Autor:
Daniel E. Singer, Steven J. Atlas, Alan S. Go, Renato D. Lopes, Steven A. Lubitz, David D. McManus, James H. Revkin, Donna Mills, Lori A. Crosson, Judith C. Lenane, Ronald S. Aronson
Publikováno v:
American heart journal. 249
Screening for atrial fibrillation (AF) is attractive because AF independently raises the risk of ischemic stroke, this risk is largely reversible by long-term oral anticoagulant therapy (OAC), and many patients with AF remain undiagnosed and untreate
Autor:
Harriette G C, Van Spall, Anuradha, Lala, Thomas F, Deering, Barbara, Casadei, Faiez, Zannad, Padma, Kaul, Roxana, Mehran, Gail D, Pearson, Monica R, Shah, Martha, Gulati, Cindy, Grines, Annabelle Santos, Volgman, James H, Revkin, Ileana, Piña, Carolyn S P, Lam, Judith S, Hochman, Tabassome, Simon, Mary N, Walsh, Biykem, Bozkurt
Publikováno v:
Journal of the American College of Cardiology. 77(23)
Women are under-represented as leaders of cardiovascular randomized controlled trials, representing 1 in 10 lead authors of cardiovascular trials published in high-impact journals. Although the proportion of cardiovascular specialists who are women h